PASG 424B3: Acquisition
Passage Bio and Remix Therapeutics have
Filed with the SEC on · accession 0001140361-26-039280
PASG filed a 424B3 (prospectus (offering)) with the SEC on Oct 9, 2026. Passage Bio and Remix Therapeutics have entered into an amended merger agreement where Remix will merge into Passage Bio in a reverse merger, with Passage Bio changing its name to Remix Therapeutics. The stock moved -1.1% by the first close after the filing.
Summary of the filing
Passage Bio and Remix Therapeutics have entered into an amended merger agreement where Remix will merge into Passage Bio in a reverse merger, with Passage Bio changing its name to Remix Therapeutics. The combined company will be owned approximately 65% by Remix equityholders, 29% by concurrent financing investors, and 6% by Passage Bio equityholders, with a concurrent financing raising approximately $100 million.
Key details
How PASG stock reacted
Close before
$3.73
Oct 8, 2026
First close after
-1.07%
$3.69
5 trading days
-3.49%
$3.60
Since filing
-7.24%
$3.46
✦ Ask GOAX AI about this filing — what it means for PASG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PASG?
Click hereFrequently asked questions
What did PASG file with the SEC on Oct 9, 2026?
PASG filed a 424B3 (Acquisition). Passage Bio and Remix Therapeutics have entered into an amended merger agreement where Remix will merge into Passage Bio in a reverse merger, with Passage Bio changing its name to Remix Therapeutics. The combined company will be owned approximately 65% by Remix equityholders, 29% by concurrent financing investors, and 6% by Passage Bio equityholders, with a concurrent financing raising approximately $100 million.
What does a acquisition mean for PASG stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did PASG stock react to this filing?
PASG closed at $3.73 before the filing and $3.69 on Oct 9, 2026 (-1.07%). Five trading days later: $3.60 (-3.49%).
Other PASG SEC filings
Get alerts when PASG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days